Peripheral Muscle Function and Body Composition in People With Cystic Fibrosis on Elexacaftor/Tezacaftor/Ivacaftor: A Cross‐Sectional Single‐Centre Study
Comparable peripheral muscle mass and function has been demonstrated in pwCF on ETI, albeit a group with good lung function. Research is needed to confirm these findings longitudinally in pwCF, including those with more severe lung disease, who are less physically active, and have less optimal nutrition and exercise support.
Authors
- Zoe L. Saynor (ORCID: https://orcid.org/0000-0003-0674-8477)
- Anthony I. Shepherd (ORCID: https://orcid.org/0000-0001-6392-7944)
- T. Daniels (ORCID: https://orcid.org/0000-0002-5249-5100)
- Jo Corbett (ORCID: https://orcid.org/0000-0002-6552-6471)
- Mark I. Allenby (ORCID: https://orcid.org/0000-0001-7403-2097)
- Mathieu Gruet (ORCID: https://orcid.org/0000-0002-2658-277X)
- Julian Legg (ORCID: https://orcid.org/0000-0002-0960-6231)
- Don S. Urquhart (ORCID: https://orcid.org/0000-0002-9048-9692)
- Gary Connett (ORCID: https://orcid.org/0000-0003-1310-3239)
- L J (ORCID: https://orcid.org/0000-0002-4907-257X)
Institutions
- Université de Toulon (FR)
- Royal Hospital for Children (GB)
- University Hospital Southampton NHS Foundation Trust (GB)
- NIHR Southampton Biomedical Research Centre (GB)
- University of Southampton (GB)
- University of Portsmouth (GB)
- University of Edinburgh (GB)
Publication Details
- Journal
- Pediatric Pulmonology
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1002/ppul.71044
- Citations
- 3
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 4.56